|
ANKFY1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.91680054845756E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.44309997074777E-09 |
| Normal-vs-Stage2 |
2.704000E-03 |
| Normal-vs-Stage3 |
1.54061999999566E-05 |
| Normal-vs-Stage4 |
1.62439999999986E-05 |
| Stage1-vs-Stage2 |
5.756200E-01 |
| Stage1-vs-Stage3 |
6.309600E-01 |
| Stage1-vs-Stage4 |
6.581000E-01 |
| Stage2-vs-Stage3 |
8.387000E-01 |
| Stage2-vs-Stage4 |
4.035000E-01 |
| Stage3-vs-Stage4 |
4.295800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23230003978847E-09 |
| Normal-vs-AfricanAmerican |
1.422580E-04 |
| Normal-vs-Asian |
5.88149999999343E-05 |
| Caucasian-vs-AfricanAmerican |
1.070190E-01 |
| Caucasian-vs-Asian |
4.645000E-01 |
| AfricanAmerican-vs-Asian |
3.951000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1943999999996E-05 |
| Normal-vs-Female |
3.45739992191341E-10 |
| Male-vs-Female |
1.517580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.55130002971782E-09 |
| Normal-vs-Age(41-60Yrs) |
1.42219999998972E-07 |
| Normal-vs-Age(61-80Yrs) |
6.23509999999605E-05 |
| Normal-vs-Age(81-100Yrs) |
5.421800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.812600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.354800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.091510E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.318400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.457900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.140400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.506600E-01 |
| Classical-VS-Follicular |
3.08950000027508E-08 |
| Classical-VS-Other |
4.943500E-02 |
| Classical-VS-Normal |
9.00612917575927E-13 |
| Tall-VS-Follicular |
2.426800E-04 |
| Tall-VS-Other |
3.471800E-02 |
| Tall-VS-Normal |
2.30489999999417E-05 |
| Follicular-VS-Other |
8.549000E-01 |
| Follicular-VS-Normal |
3.306000E-01 |
| Other-VS-Normal |
7.947000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.60369999999433E-06 |
| Normal-vs-N1 |
3.459800E-03 |
| N0-vs-N1 |
9.040000E-01 |
|
|
